NCT03736772View on ClinicalTrials.gov

A Study of LY3090106 in Japanese and Caucasian Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

March 13, 2019

Study Completion Date

March 13, 2019

Conditions
Healthy
Interventions
DRUG

LY3090106

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

92801

Anaheim Clinical Trials, LLC, Anaheim

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03736772 - A Study of LY3090106 in Japanese and Caucasian Healthy Participants | Biotech Hunter | Biotech Hunter